SRA International Inc. has sold its contract research organization to Aptiv Solutions Inc.
The Fairfax-based IT contractor said the transaction is effective immediately and did not disclose terms of the deal. In March, SRA announced that it would divest SRA Global Clinical Development LLC and its subsidiaries.
“We believe the GCD business, as a part of Aptiv Solutions, has greater opportunity to pursue a wider range of initiatives that align with its mission,” SRA President and CEO Bill Ballhaus said in a statement.
Aptiv Solutions, based in Reston, is a global biopharmaceutical and medical device development services company.
There are no comments for this entry